Additionally, lifestyle changes accompanying medication use, such as altered diet or fluid intake, might contribute to digestive changes
For weight management, the FDA labels these drugs as treatments for chronic obesity, intended for continued use
Advances in enteric coating, nanoparticle encapsulation, and peptide stapling are opening pathways to oral bioavailability a potential game-changer for therapeutic applications
While Ozempic and Mounjaro are technically labeled for diabetes management, their weight-loss counterparts utilize the exact same underlying molecules to suppress appetite and improve insulin sensitivity
Some readers have told us about: severe digestive problems hair loss dizziness changes in vision fatigue or muscle weakness Others say the drugs have worked remarkably well with very few problems
These medications mimic a natural hormone that regulates blood sugar and slows digestion, helping you feel fuller for longer while reducing cravings